Parametric Portfolio Associates’s Sensus Healthcare SRTS Stock Holding History

Parametric Portfolio Associates’s Portfolio SRTS Stock Details SRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.46M	Buy	+144,210	New	+$1.32M	﹤0.01%	2585

Other funds holding SRTS

HIM

Hillsdale Investment Management Toronto, Ontario, Canada $3.68B AUM 62.12% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

EGI

EAM Global Investors Solana Beach, California $47.1M AUM 320.45% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Parametric Portfolio Associates's SRTS Position: Q1 2022 in Review

Parametric Portfolio Associates opened a new position in Sensus Healthcare (SRTS) in Q1 2022: 144,210 shares worth $1.46M. The stake represents ﹤0.01% of the portfolio and ranks #2585 among its holdings.

54 funds tracked by Wall St. Rank hold SRTS as of Q1 2022.

Parametric Portfolio Associates held 144,210 shares of Sensus Healthcare worth $1.46M as of Q1 2022.
Sensus Healthcare was a new Parametric Portfolio Associates position in Q1 2022.
Sensus Healthcare made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2585 holding.
54 funds tracked by Wall St. Rank held Sensus Healthcare as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.